Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study

Idanna Innocenti; Gianluigi Reda; Andrea Visentin; Marta Coscia; Marina Motta; Roberta Murru; Riccardo Moia; Massimo Gentile; Elsa Pennese; Francesca Maria Quaglia; Francesco Albano; Ramona Cassin; Marina Deodato; Claudia Ielo; Anna Maria Frustaci; Alfonso Piciocchi; Arianna Rughini; Valentina Arena; Daniela Di Sevo; Annamaria Tomasso; Francesco Autore; Giovanni Del Poeta; Lydia Scarfò; Francesca Romana Mauro; Alessandra Tedeschi; Livio Trentin; Maurizio Pompili; Robin Foà; Paolo Ghia; Antonio Cuneo; Luca Laurenti

doi:10.3324/haematol.2021.280325

Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study

Idanna Innocenti
, Gianluigi Reda
, Andrea Visentin
, Marta Coscia
, Marina Motta
, Roberta Murru
, Riccardo Moia
, Massimo Gentile
, Elsa Pennese
, Francesca Maria Quaglia
, Francesco Albano
, Ramona Cassin
, Marina Deodato
, Claudia Ielo
, Anna Maria Frustaci
, Alfonso Piciocchi
, Arianna Rughini
, Valentina Arena
, Daniela Di Sevo
, Annamaria Tomasso

Francesco Autore, Giovanni Del Poeta, Lydia Scarfò, Francesca Romana Mauro, Alessandra Tedeschi, Livio Trentin, Maurizio Pompili, Robin Foà, Paolo Ghia, Antonio Cuneo, Luca Laurenti

IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
University of Padua
Azienda Ospedaliera - Universitaria Città della Salute e della Scienza di Torino
Spedali Civili Di Brescia
AO Brotzu
University of Eastern Piedmont
Presidio Ospedaliero Annunziata
Ospedale S. Spirito
University of Verona
University of Bari
Asst Grande Ospedale Metropolitano Niguarda
University “La Sapienza” of Rome
GIMEMA Foundation
University of Rome Tor Vergata
San Raffaele Scientific Institute
University of Ferrara

Research output: Contribution to journal › Article

Abstract

N/A

Original language	English
Pages (from-to)	1470-1473
Number of pages	4
Journal	Haematologica
DOIs	https://doi.org/10.3324/haematol.2021.280325
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Chronic lymphocytic leukemia
HBV reactivation
ibrutinib
occult HBV infection

Access to Document

10.3324/haematol.2021.280325

Cite this

Innocenti, I., Reda, G., Visentin, A., Coscia, M., Motta, M., Murru, R., Moia, R., Gentile, M., Pennese, E., Quaglia, F. M., Albano, F., Cassin, R., Deodato, M., Ielo, C., Frustaci, A. M., Piciocchi, A., Rughini, A., Arena, V., Di Sevo, D., ... Laurenti, L. (2022). Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study. Haematologica, 1470-1473. https://doi.org/10.3324/haematol.2021.280325

@article{d9e712a0d5a64f44b65a0001c9986942,

title = "Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study",

abstract = "N/A",

keywords = "Chronic lymphocytic leukemia, HBV reactivation, ibrutinib, occult HBV infection, Chronic lymphocytic leukemia, HBV reactivation, ibrutinib, occult HBV infection",

author = "Idanna Innocenti and Gianluigi Reda and Andrea Visentin and Marta Coscia and Marina Motta and Roberta Murru and Riccardo Moia and Massimo Gentile and Elsa Pennese and Quaglia, \{Francesca Maria\} and Francesco Albano and Ramona Cassin and Marina Deodato and Claudia Ielo and Frustaci, \{Anna Maria\} and Alfonso Piciocchi and Arianna Rughini and Valentina Arena and \{Di Sevo\}, Daniela and Annamaria Tomasso and Francesco Autore and \{Del Poeta\}, Giovanni and Lydia Scarf{\`o} and Mauro, \{Francesca Romana\} and Alessandra Tedeschi and Livio Trentin and Maurizio Pompili and Robin Fo{\`a} and Paolo Ghia and Antonio Cuneo and Luca Laurenti",

year = "2022",

doi = "10.3324/haematol.2021.280325",

language = "English",

pages = "1470--1473",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

}

Innocenti, I, Reda, G, Visentin, A, Coscia, M, Motta, M, Murru, R, Moia, R, Gentile, M, Pennese, E, Quaglia, FM, Albano, F, Cassin, R, Deodato, M, Ielo, C, Frustaci, AM, Piciocchi, A, Rughini, A, Arena, V, Di Sevo, D, Tomasso, A, Autore, F, Del Poeta, G, Scarfò, L, Mauro, FR, Tedeschi, A, Trentin, L, Pompili, M, Foà, R, Ghia, P, Cuneo, A & Laurenti, L 2022, 'Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study', Haematologica, pp. 1470-1473. https://doi.org/10.3324/haematol.2021.280325

TY - JOUR

T1 - Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study

AU - Innocenti, Idanna

AU - Reda, Gianluigi

AU - Visentin, Andrea

AU - Coscia, Marta

AU - Motta, Marina

AU - Murru, Roberta

AU - Moia, Riccardo

AU - Gentile, Massimo

AU - Pennese, Elsa

AU - Quaglia, Francesca Maria

AU - Albano, Francesco

AU - Cassin, Ramona

AU - Deodato, Marina

AU - Ielo, Claudia

AU - Frustaci, Anna Maria

AU - Piciocchi, Alfonso

AU - Rughini, Arianna

AU - Arena, Valentina

AU - Di Sevo, Daniela

AU - Tomasso, Annamaria

AU - Autore, Francesco

AU - Del Poeta, Giovanni

AU - Scarfò, Lydia

AU - Mauro, Francesca Romana

AU - Tedeschi, Alessandra

AU - Trentin, Livio

AU - Pompili, Maurizio

AU - Foà, Robin

AU - Ghia, Paolo

AU - Cuneo, Antonio

AU - Laurenti, Luca

PY - 2022

Y1 - 2022

N2 - N/A

AB - N/A

KW - Chronic lymphocytic leukemia

KW - HBV reactivation

KW - ibrutinib

KW - occult HBV infection

KW - Chronic lymphocytic leukemia

KW - HBV reactivation

KW - ibrutinib

KW - occult HBV infection

UR - http://hdl.handle.net/10807/204488

U2 - 10.3324/haematol.2021.280325

DO - 10.3324/haematol.2021.280325

M3 - Article

SN - 0390-6078

SP - 1470

EP - 1473

JO - Haematologica

JF - Haematologica

ER -

Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this